4/A//SEC Filing
Hyman Steven 4/A
Accession 0001140361-22-027144
CIK 0001755237other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:40 PM ET
Size
5.2 KB
Accession
0001140361-22-027144
Insider Transaction Report
Form 4/AAmended
Hyman Steven
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-25+57,753→ 57,753 totalExercise: $0.78Exp: 2032-07-25→ Common Stock (57,753 underlying)
Footnotes (1)
- [F1]The options were granted pursuant to the director compensation plan. 17,753 options will vest in full on the first anniversary of the grant date and 40,000 options will vest monthly pro rata over 36 months starting on the grant date.
Documents
Issuer
Cyclerion Therapeutics, Inc.
CIK 0001755237
Entity typeother
Related Parties
1- filerCIK 0001656506
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:40 PM ET
- Size
- 5.2 KB